Reply to: fatigue in bone: a novel phenomenon attributable to bisphosphonate use

Comment

David B Burr et al. Bone. 2010 Aug.

. 2010 Aug;47(2):455.

doi: 10.1016/j.bone.2010.04.603. Epub 2010 May 4.

No abstract available

Comment on

Fatigue in bone: a novel phenomenon attributable to bisphosphonate use.
Kyrgidis A, Verrou E. Kyrgidis A, et al. Bone. 2010 Feb;46(2):556; author reply 557-8. doi: 10.1016/j.bone.2009.09.026. Epub 2009 Sep 29. Bone. 2010. PMID: 19796720 No abstract available.

Fatigue in bone: a novel phenomenon attributable to bisphosphonate use.
Kyrgidis A, Verrou E. Kyrgidis A, et al. Bone. 2010 Feb;46(2):556; author reply 557-8. doi: 10.1016/j.bone.2009.09.026. Epub 2009 Sep 29. Bone. 2010. PMID: 19796720 No abstract available.
Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw.
Setabutr D, Hales NW, Krempl GA. Setabutr D, et al. Am J Otolaryngol. 2010 Mar-Apr;31(2):127-9. doi: 10.1016/j.amjoto.2008.11.002. Epub 2009 Mar 26. Am J Otolaryngol. 2010. PMID: 20015718
Bisphosphonate medications--the good, the bad, and the ugly.
Bourgeois SL Jr. Bourgeois SL Jr. Tex Dent J. 2009 Jul;126(7):596-604. Tex Dent J. 2009. PMID: 19753815 Review. No abstract available.
Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions.
Woo SB, Solomon DH. Woo SB, et al. J Natl Cancer Inst. 2007 Jul 4;99(13):986-7. doi: 10.1093/jnci/djm029. Epub 2007 Jun 27. J Natl Cancer Inst. 2007. PMID: 17596571 No abstract available.
Bisphosphonate-related osteonecrosis of the jaw presenting as a cutaneous dental sinus tract: a case report and review of the literature.
Truong SV, Chang LC, Berger TG. Truong SV, et al. J Am Acad Dermatol. 2010 Apr;62(4):672-6. doi: 10.1016/j.jaad.2008.09.021. Epub 2010 Feb 11. J Am Acad Dermatol. 2010. PMID: 20153079 Review.